| Aug 1 |
Agios Pharmaceuticals: Q2 Earnings Snapshot
|
| Aug 1 |
Agios Reports Business Highlights and Second Quarter 2024 Financial Results
|
| Aug 1 |
Agios Announces Results from Phase 3 ACTIVATE-KidsT Study of Mitapivat in Children with PK Deficiency Who Are Regularly Transfused
|
| Jul 31 |
Agios Pharmaceuticals Q2 2024 Earnings Preview
|
| Jul 29 |
Analysts Estimate Quanterix Corporation (QTRX) to Report a Decline in Earnings: What to Look Out for
|
| Jul 25 |
Agios Pharmaceuticals (AGIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
|
| Jul 24 |
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Has Found A Path To Profitability
|
| Jul 18 |
Agios to Webcast Conference Call of Second Quarter 2024 Financial Results on August 1, 2024
|
| Jun 24 |
Agios Pharmaceuticals (AGIO) Surges 6.5%: Is This an Indication of Further Gains?
|
| Jun 23 |
Semiconductor Setbacks Bolster Market Breadth – The Market Breadth
|
